"As enduring supporters of Tampa General Hospital, we've greatly admired the unique combination of clinical expertise and top-tier compassionate care given by Dr. Marcet and the colorectal team at the TGH Cancer Institute," said John and Susan Sykes. "We are excited to help establish a new Center of Excellence in Colorectal Cancer, with the goal of continuously advancing the treatment and care for patients today and tomorrow."
"Through their philanthropy and kindness, the Sykes' will play an active role in helping patients to have more opportunities for treatment and a better quality of life," Marcet said. "We are endlessly grateful for this highly meaningful gift. At a time when colon cancer rates are rising in people younger than 50 and in an environment of rapid advances in cancer care, an important role of the Susan and John Sykes Center of Excellence in Colorectal Cancer will be to serve as a resource for the education and training of future physicians and nurses as experts in the field, and will help foster innovation in the development of new and improved treatment approaches for colorectal diseases in our community."
"We are so honored that the Sykes' have chosen to support Tampa General and the Cancer Institute with this generous gift," said Frann Leppla, senior vice president of development and chief philanthropy officer of the TGH Foundation. "It will significantly boost our efforts to drive innovation and provide world-class, research-driven care to patients across the Tampa Bay region and the state."
In 2022, the TGH Cancer Institute earned a three-year accreditation from the Commission on Cancer, a quality program established by the American College of Surgeons. In 2023, Newsweek listed the TGH Cancer Institute in the top 3% of cancer hospitals in the United States and Becker's Hospital Review named the academic health system to its list of 100 Top Hospitals and Health Systems with Great Oncology Programs.
Tampa General's cancer physicians offer the highest level of multidisciplinary care in the treatment of lung, colorectal, breast, prostate, gynecologic, head and neck, neurologic and hematologic malignancies, including specialized care in organ transplantation, bone marrow transplant and cell therapies within the framework of a nationally recognized academic health care center.
For more information about the TGH Cancer Institute, visit https://www.tgh.org/institutes-and-services/cancer-institute.
